About OCION
The importance of the immune system in cancer biology has long been understood. However, the clinical use of cancer immunotherapy - treatments that take advantage of the body's immune system to fight cancer – is still in its infancy.
Launched in 2023, OCION was established to bring together scientists from different disciplines, cutting-edge technologies and patient samples to progress our immuno-oncology understanding to the next level. By applying our leading expertise in fundamental immunology, we hope to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use.
